Expert Talk

Oligonucleotide CMC & Manufacturing

With the rapid expansion of oligonucleotide therapeutics into formats such as AOCs novel conjugates pegRNAs and multivalent

Microbiome and Microbial Omics Data in Clinical Stages

Exploring the Facts, Fictions, and Bottlenecks

Specifically in microbiome testing there is so much to gain from a fast gotomarket strategy that is the moment you start capturing

Strategic Visibility

How Media Partnerships Are Redefining B2B Pharma Events

Pharma events have transitioned from being standalone networking opportunities to becoming strategic industry platforms

How AI is Reshaping Compliance and Quality Management in the Life Sciences Sector in 2025

AI is shifting the role of quality professionals from messengers to datadriven decisionmakers Traditionally

Clinical Trial Modernization

Technological, Operational, and Regulatory Advances

The transformation of clinical trials is driven by a convergence of operational inefficiencies technological

RNA, CAR-T & CRISPR

Engineering the Next Frontier of Medicine

CART has matured with approvals reimbursement and expanding use but now its optimizing not reinventing

AI in Regulatory Affairs

Between Promise and Proof

AI adoption in regulatory functions truly gaining ground across biopharma or does it remain mostly confined

Sustainable Innovation in Biopharma: Aligning Therapeutic Progress with Environmental Responsibility

To genuinely align RD with environmental responsibility biopharma organisations must embrace systemic structural and cultural transformations

Targeted Therapies for Cancer

The last decade has shown a paradigm shift in understanding cancer including treatment options and patient outcomes

Biochemical and Molecular Pharmacology in Drug Discovery

My extensive experience in pharmaceutical sciences played a pivotal role in conceptualizing and